Legal Representation
Attorney
Garrett M. Weber
USPTO Deadlines 2 active 2 overdue
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
EXAMINER AMENDMENT
Examiner's Amendment Completed |
CNEA | Oct 03, 2019 | 2104 days overdue | Low | No |
|
OPPOSITION
Notice of Publication |
NPUB | Nov 28, 2019 | 2048 days overdue | Medium | Until Dec 28, 2019 |
Application History
15 events| Date | Code | Type | Description |
|---|---|---|---|
| Jan 14, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Jan 14, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Oct 29, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Oct 29, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Oct 9, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sep 23, 2019 | ALIE | A | ASSIGNED TO LIE |
| Sep 18, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 18, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Sep 18, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Sep 18, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Sep 18, 2019 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Sep 17, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
| Jul 10, 2019 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Jul 9, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jul 1, 2019 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 035
Business management and consulting services for the health care industry, namely, business management of cell, gene and other complex medical therapies for health plans, health insurers, self-funded plans, and reinsurers; business management and administration in the field of healthcare, namely, development, creation and implementation of health care provider networks; business administration of cell, gene and other complex therapy programs
First Use Anywhere:
Jun 13, 2019
First Use in Commerce:
Jun 13, 2019
Class 036
Financial consultation to healthcare providers, namely, providing assistance in obtaining reimbursement of health care expenses related to cell, gene and other complex therapies
First Use Anywhere:
Jun 13, 2019
First Use in Commerce:
Jun 13, 2019
Class 044
Consulting services in the field of medical care, namely, developing medical treatment policies related to cell, gene, and other complex therapies; medical information services related to cell, gene and other complex therapies
First Use Anywhere:
Jun 13, 2019
First Use in Commerce:
Jun 13, 2019
Additional Information
Design Mark
The mark consists of the letters "ETS" in large bold lettering, above the words "EMERGING THERAPY SOLUTIONS", in smaller lettering. To the left of the letters and words are two hexagons, one on top of the other, and slanted to the right. To the left of the slanted hexagons is a smaller hexagon, also slanted to the right.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
035
036
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"EMERGING THERAPY SOLUTIONS"